Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell

Figure 4

RAC2 mRNA expression and protein levels in human cancers. (a) The RAC2 mRNA expression in different cancer or some cancer subtypes and the corresponding adjacent tissues was analyzed by TIMER2. (b) Box plots comparing RAC2 expression levels in 10 cancers (TCGA project) relative to control tissues (GTEx database). (c) The expression levels of total RAC2 protein in normal tissues versus BRCA, KIRC, COAD, GBM, and HNSC. (d) Stage-dependent expression levels of RAC2. According to TCGA data, the mRNA expression levels of RAC2 at different pathological stages of 7 cancers.

(a)

(b)

(c)

(d)